Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Adrenoleukodystrophy - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. This "Adrenoleukodystrophy - Pipeline ...

Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "Cerebral Adrenoleukodystrophy - Pipeline Insight, 2024" has been added to ResearchAndMarkets.com's offering. The report provides comprehensive insights ...

This rare and devastating genetic disease can now be effectively treated with haploidentical stem cell transplantation.

Cerebral adrenoleukodystrophy (CALD) is a rare progressive, genetic brain disease that primarily presents in young boys, causing loss of neurological function and ultimately leading to early death.

(MENAFN- GlobeNewsWire - Nasdaq) The global adrenoleukodystrophy market is in a growth stage, driven by advancements in gene and drug therapies, improved diagnostic capabilities like newborn screening ...

Adrenoleukodystrophy (ALD) is rare X-linked genetic disease that affects the adrenal glands (found on top of the kidneys) as well as the myelin in the brain and spinal cord. The incidence of ALD is ...

LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with ...

Dublin, July 11, 2025 (GLOBE NEWSWIRE) -- The "Adrenoleukodystrophy Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's ...